Key facts
- This page summarizes David Natan's Form 4 filing for Sunshine Biopharma Inc. (SBFM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2026, 16:23.
David Natan - 07 Aug 2026 Form 4 Insider Report for Sunshine Biopharma Inc. (SBFM)
- Reporting relationship
- Director
- Issuer ticker
- SBFM
- Reported as of
- 07 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2026, 16:23:05 UTC
- Prior SEC filing
- 04 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Natan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David Natan filed Form 4 for Sunshine Biopharma Inc. (SBFM) on 11 Aug 2026.
Change
- Previous filing in this sequence was filed on 04 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001253108
Primary reporting owner
NATAN DAVID
- Relationship
- Director
- Address
- C/O SUNSHINE BIOPHARMA, INC., 333 LA OLAS WAY, CU SUITE 433, FORT LAUDERDALE
- Signature
- /s/ David Natan
- Signature date
- 11 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SBFM
transaction
Common Stock
Award
- Transaction value
- Shares
- +58,300
- Change %
- +583%
- Price
- $0.000000*
- Shares after
- 68,300
- Date
- 07 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents a stock award to the reporting person.